EU Recommends Approval of Neoadjuvant Pertuzumab RegimenEU Recommends Approval of Neoadjuvant Pertuzumab Regimen

CHMP has cleared the way for approval of pertuzumab combined with traztuzumab and other agents in the neoadjuvant setting for women with early HER2-positive breast cancer. International Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news